| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9758 |
| Human Intestinal Absorption | HIA+ | 0.9913 |
| Caco-2 Permeability | Caco2+ | 0.7372 |
| P-glycoprotein Substrate | Non-substrate | 0.8956 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9765 |
| Non-inhibitor | 0.9903 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9215 |
| Distribution |
| Subcellular localization | Lysosome | 0.5942 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8443 |
| CYP450 2D6 Substrate | Non-substrate | 0.8344 |
| CYP450 3A4 Substrate | Non-substrate | 0.8266 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8598 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8992 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9686 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9331 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9853 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7956 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9638 |
| Non-inhibitor | 0.9738 |
| AMES Toxicity | Non AMES toxic | 0.9470 |
| Carcinogens | Carcinogens | 0.6471 |
| Fish Toxicity | High FHMT | 0.6004 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5333 |
| Honey Bee Toxicity | High HBT | 0.8726 |
| Biodegradation | Not ready biodegradable | 0.7810 |
| Acute Oral Toxicity | III | 0.5765 |
| Carcinogenicity (Three-class) | Non-required | 0.5045 |